DOI: https://dx.doi.org/10.18565/urology.2019.16.35-39
И.А. Абоян, В.Э. Абоян, С.В. Павлов, О.В. Зиньковская, Д.С. Павлов
1) МБУЗ «Клинико-диагностический центр “Здоровье”», Ростов-на-Дону, Россия; 2) Ростовский государственный медицинский университет, Ростов-на-Дону, Россия
1. Engeler D., Baranowski A.P., Borovicka J. et al. EAU Guidelines on Chronic Pelvic Pain. 2016. Available online at: https://uroweb.org/guideline/chronic-pelvic-pain/ 2. Nordling J., Fall M., Hanno P. Global concepts of bladder pain syndrome (interstitial cystitis). World J Urol. 2012;30:457–464. 3. Bogart L.M., Suttorp M.J., Elliott M.N., Clemens J.Q., Berry S.H. Prevalence and correlates of sexual dysfunction among women with bladder pain syndrome/interstitial cystitis. Urology. 2011;77:576–580. 4. Hanno P.M. Bladder pain syndrome (interstitial cystitis) and related disorder; in Wein A.J., Kavoussi L.R., Novick A.C., Partin A.W., Peters C.A. (eds). Campbell-Walsh urology. 11th ed. Philadelphia, Saunders. 2016;1:334–370. 5. Konkle K.S., Berry S.H., Elliott M.N. et al. Comparison of an interstitial cystitis/bladder pain syndrome clinical cohort with symptomatic community women from the RAND Interstitial Cystitis Epidemiology study. J Urol. 2012;187:508. 6. Moldwin R.M., Sant G.R. Interstitial cystitis: a pathophysiology and treatment update. ClinObstet Gynecol. 2002;45:259–272. 7. Ignashov Yu.A., Kuz’min I.V., Slesarevskaya M.N. Bladder pain syndrome: the historical aspects. Istoriya mediciny. 2016;6(3):5–10. Russian (Игнашов Ю.А., Кузьмин И.В., Слесаревская М.Н. Синдром болезненного мочевого пузыря: исторические аспекты. История медицины. 2016;6(3):5–10). 8. Hurst R.E. Structure, function, and pathology of proteoglycans and glycosaminoglycans in the urinary tract. World J Urol. 1994;12:3. 9. Cervigni M., Natale F., Nasta L., Mako A. Intravesical hyaluronic acid and chondroitin sulphate for bladder pain syndrome/interstitial cystitis: long-term treatment results. Int Urogynecol J. 2012;23:1187–1192. 10. Morales A., Emerson L., Nickel J.C., Lundie M. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. J Urol. 1996;156:45–48. 11. Gülpınar Ö., Esen B., Kayış A., Gökçe M.İ., Süer E. Clinical comparison of intravesical hyaluronic acid and chondroitin sulfate therapies in thetreatment of bladder pain syndrome/interstitial cystitis. Neurourol Urodyn. 2018;37(1):257–262. Doi: 10.1002/nau.23284.Epub 2017 May 8. 12. Hurst R.E. Structure, function, and pathology of proteoglycans and glycosaminoglycans in the urinary tract. World J Urol. 1994;12:3. 13. Hanno P., Baranowski A., Fall M. et al. Painful bladder syndrome (including interstitial cystitis). In: Abrams PH, Wein AJ, CardozoL, eds. Incontinence (3rd ed.) Paris: Health Publications Limited. 2005:1456–1520. 14. Steinhoff G., Ittah B., Rowan S. The efficacy of chondroitin sulfate 0.2% in treating interstitial cystitis. Can J Urol. 2002;9:1454. 15. Porru D. et al., Impact of intravesical hyaluronic acid and chondroitin sulfate on bladder pain syndrome/interstitial cystitis. IntUrogynecol J. 2012;23(9):1193–199. Doi:10.1007/s00192-011-1546-5. 16. Cervigni M. et al. A randomized, open-label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate versus dimethyl sulfoxide in women with bladder pain syndrome/interstitial cystitis. NeurourolUrodyn. 2017;36(4):1178–1186. Doi: 10.1002/nau.23091. 17. Torella M., Del Deo F., Grimaldi A., Iervolino S.A., Pezzella M., Tammaro C.,Gallo P., Rappa C., De Franciscis P., Colacurci N. Efficacy of an orally administered combination of hyaluronic acid, chondroitin sulfate, curcumin and quercetin for the prevention of recurrent urinary tract infections in postmenopausal women. Eur J Obstet Gynecol Reprod Biol. 2016;207:125–128. 18. Theoharides T.C., Kempuraj D., Vakali S., Sant G.R. Treatment of refractory interstitial cystitis/painful bladder syndrome with CystoProtek –an oral multi-agent natural supplement. Can J Urol. 2008;15(6):4410–14. 19. Hurst R.E., Zebrowski R. Identification of proteoglycans present at high density on bovine and human bladder luminal surface. J Urol. 1994;152:1641.
А в т о р д л я с в я з и: В. Э. Абоян – к.м.н., врач-уролог МБУЗ КДЦ «Здоровье», Ростов-на-Дону, Россия;
e-mail: v-aboyan@yandex.ru